Evidence map›Paper›PMID 34202641›Full record

ReviewInternational journal of molecular sciences2021

Cohesin Mutations in Cancer: Emerging Therapeutic Targets.

Jisha Antony, Chue Vin Chin, Julia A Horsfield

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Cohesin mutations and chromatin changes in cancer.International journal of cancer · 2026
    Review
  7. Article
  8. Article
  9. Aberrant cohesin function inbioRxiv : the preprint server for biology · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Cohesin regulation and roles in chromosome structure and function.Current opinion in genetics & development · 2024
    Review
  18. Article
  19. Role of chromosomal cohesion and separation in aneuploidy and tumorigenesis.Cellular and molecular life sciences : CMLS · 2024
    Review
  20. STAG2: Computational Analysis of Missense Variants Involved in Disease.International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jisha AntonyDepartment of Pathology, Otago Medical School, University of Otago, Dunedin 9016, New Zealand.
Chue Vin ChinDepartment of Pathology, Otago Medical School, University of Otago, Dunedin 9016, New Zealand.
Julia A HorsfieldDepartment of Pathology, Otago Medical School, University of Otago, Dunedin 9016, New Zealand.ORCID 0000-0002-9536-7790
University of Auckland · NZUniversity of Otago · NZ

Funding

Health Research Council of New Zealand 19/415
6 · The paper itself

Abstract

The cohesin complex is crucial for mediating sister chromatid cohesion and for hierarchal three-dimensional organization of the genome. Mutations in cohesin genes are present in a range of cancers. Extensive research over the last few years has shown that cohesin mutations are key events that contribute to neoplastic transformation. Cohesin is involved in a range of cellular processes; therefore, the impact of cohesin mutations in cancer is complex and can be cell context dependent. Candidate targets with therapeutic potential in cohesin mutant cells are emerging from functional studies. Here, we review emerging targets and pharmacological agents that have therapeutic potential in cohesin mutant cells.

Indexed as

Genetic Predisposition to DiseaseMutationBiomarkers, TumorCell Cycle ProteinsChromosomal Proteins, Non-HistoneCohesinsDisease ManagementDNA-Binding ProteinsDNA RepairGene Expression RegulationHumansMolecular Targeted TherapyNeoplasmsOrgan SpecificityProtein BindingStructure-Activity RelationshipBiomarkers, TumorCell Cycle ProteinsChromosomal Proteins, Non-HistoneCohesinsDNA-Binding Proteinscancercohesinsynthetic lethaltherapeuticstranscription

Identifiers

PMID34202641
PMCPMC8269296
OpenAlexW3175185076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.